Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, van de Donk NWCJ, Katodritou E, Schjesvold F, Balari AS, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted Aet al.(2024) A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma Future Oncol, 1-21(in press) DOI 10.1080/14796694.2024.2394323, PubMed 39287147
Hamnvik LHD, Eide-Olsen S, Fosseng A, Schjesvold FH(2024) Estimated Financial Savings From Clinical Studies at Oslo Myeloma Center in the Period 2015-2021 Clin Lymphoma Myeloma Leuk(in press) DOI 10.1016/j.clml.2024.07.015, PubMed 39191633
Abdollahi P, Norseth HM, Schjesvold F(2024) Advances and challenges in anti-cancer vaccines for multiple myeloma Front Immunol, 15, 1411352 DOI 10.3389/fimmu.2024.1411352, PubMed 39161773
